N-(2,4-Dichlorophenyl)-1H-1,2,3-triazole-4-carboxamide

Catalog No. :
ACQLQD830
CAS No. :
936323-17-0
Molecular Formula :
C9H6Cl2N4O
Molecular Weight :
257.08

IUPAC Name:N-(2,4-dichlorophenyl)-1H-1,2,3-triazole-4-carboxamide

N-(2,4-Dichlorophenyl)-1H-1,2,3-triazole-4-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$236.00Login to see priceInquiryInquiry
100mg95%$340.00Login to see priceInquiryInquiry
250mg95%$477.00Login to see priceInquiryInquiry
1g95%$948.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2,4-Dichlorophenyl)-1H-1,2,3-triazole-4-carboxamide
IUPAC NameN-(2,4-dichlorophenyl)-1H-1,2,3-triazole-4-carboxamide
MDL No.MFCD23718370
Molecular FormulaC9H6Cl2N4O
Molecular Weight257.08
SMILESO=C(C1=CNN=N1)NC2=CC=C(Cl)C=C2Cl
InChI KeyGAGGCNZJYKWGJL-UHFFFAOYSA-N
SynonymN-(2,4-dichlorophenyl)-1H-1,2,3-triazole-4-carboxamide;1H-1,2,3-Triazole-5-carboxamide, N-(2,4-dichlorophenyl)-
CAS No.936323-17-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACQLQD830 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIPQM534 route compound structure diagram
    ACIPQM5344343-72-0 In Stock
  4. Then
  5. ACQLQD830 route product structure diagram
    ACQLQD830936323-17-0
Inquiry

2. ACQLQD830 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQLQD830 route product structure diagram
    ACQLQD830936323-17-0
Inquiry

Comments (0)